Atlas Trials

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

Clinical trial NCT06833502 · RECRUITING

Trial details

NCT number
NCT06833502
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerNode-positive Breast Cancer
Start date
2025-02-24
Primary completion
2026-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.